Medtronic (MDT) Highlights New Data from CRYO4PERSISTENT AF Clinical Trial Evaluating Patients with Symptomatic Persistent AF Treated with Cryoballoon at 2018 ESC Congress
August 28, 2018 9:09 AM
Medtronic plc (NYSE: MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
